PROVO, Utah, May 13, 2013 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced that its executive management team recently met with the company's top international sales leaders in Kauai, Hawaii to unveil ageLOC® TR90™, the highly-anticipated weight management and body shaping system that is scheduled to begin rolling out in the second half of the year. The ageLOC TR90 system is the latest product in the company's successful ageLOC anti-aging product portfolio, which focuses on providing nutritional and skin care solutions that target the sources of aging.
"We were extremely pleased with the positive reaction of our top sales leaders as we released the details of our new ageLOC TR90 system," said Truman Hunt, president and chief executive officer. "This latest ageLOC offering adds to our successful anti-aging product portfolio, capitalizing on one of the largest consumer product categories—weight management. Given the strength of the new ageLOC weight management system, the enthusiasm of our sales leaders and the great potential of this consumer category, we anticipate the global limited-time offer in the second half of the year will be our largest product launch ever."
Powered by Nu Skin's exclusive anti-aging science, ageLOC TR90 was developed to enable consumers to begin to transform their body composition in just 90 days. It includes four proprietary nutritional products and science-based eating plan, along with lifestyle suggestions, to help consumers reach their goals. The nutritional supplements in the ageLOC weight management system are designed to target three important areas for weight management: healthy metabolism, lean muscle and appetite control.
"Our research shows that many weight management programs focus on maximizing pounds lost, whether the weight comes from fat, muscle or both," said Joseph Chang, Ph.D., chief scientific officer and executive vice president, product development. "In contrast, we are focusing our system on improving overall body composition—with the ideal of supporting the maintenance of lean muscle while promoting healthy, overall weight loss."
Nu Skin plans to introduce the ageLOC TR90 system as a limited-time offer at its global convention in October, with regional introductions taking place throughout 2014.
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. The company's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company. The company's anti-aging products feature the new ageLOC® suite of products including the ageLOC® R2 nutritional supplement, ageLOC® Galvanic Spa System and ageLOC® Galvanic Body Spa™, as well as the ageLOC® Transformation daily skin care system. A global direct selling company, Nu Skin operates in 53 markets worldwide and is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskin.com.
Please Note: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the company's performance, initiatives, strategies and new product introductions; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.
The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:
- any failure of planned initiatives or products to generate interest among distributors and consumers;
- risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support our planned initiatives or launch strategies, including possible ingredient supply limitations;
- risks that order cancellations, product returns, and cannibalization of other product sales will exceed management's expectations; and
- regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit the company's ability to import or sell a product in a market if it is unable to register the product in a timely manner under applicable regulatory requirements.
The forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.
SOURCE Nu Skin Enterprises, Inc.